Syljuåsen RG - Search Results

1

MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.

Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z. Li X, et al. Among authors: syljuasen rg. Oncotarget. 2016 Jun 28;7(26):40297-40313. doi: 10.18632/oncotarget.9610. Oncotarget. 2016. PMID: 27248169 Free PMC article.

2

Hypoxia-induced alterations of G2 checkpoint regulators.

Hasvold G, Lund-Andersen C, Lando M, Patzke S, Hauge S, Suo Z, Lyng H, Syljuåsen RG. Hasvold G, et al. Among authors: syljuasen rg. Mol Oncol. 2016 May;10(5):764-73. doi: 10.1016/j.molonc.2015.12.015. Epub 2016 Jan 8. Mol Oncol. 2016. PMID: 26791779 Free PMC article.

3

Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading.

Hauge S, Naucke C, Hasvold G, Joel M, Rødland GE, Juzenas P, Stokke T, Syljuåsen RG. Hauge S, et al. Among authors: syljuasen rg. Oncotarget. 2017 Feb 14;8(7):10966-10979. doi: 10.18632/oncotarget.14089. Oncotarget. 2017. PMID: 28030798 Free PMC article.

4

Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.

Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z. Li X, et al. Among authors: syljuasen rg. Oncotarget. 2017 Jan 24;8(4):7208-7213. doi: 10.18632/oncotarget.14800. Oncotarget. 2017. PMID: 28179591 Free PMC article. No abstract available.

5

The efficacy of CHK1 inhibitors is not altered by hypoxia, but is enhanced after reoxygenation.

Hasvold G, Nähse-Kumpf V, Tkacz-Stachowska K, Rofstad EK, Syljuåsen RG. Hasvold G, et al. Among authors: syljuasen rg. Mol Cancer Ther. 2013 May;12(5):705-16. doi: 10.1158/1535-7163.MCT-12-0879. Epub 2013 May 1. Mol Cancer Ther. 2013. PMID: 23635654

6

p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors.

Petersen L, Hasvold G, Lukas J, Bartek J, Syljuåsen RG. Petersen L, et al. Among authors: syljuasen rg. Cell Prolif. 2010 Aug;43(4):365-71. doi: 10.1111/j.1365-2184.2010.00685.x. Cell Prolif. 2010. PMID: 20590661 Free PMC article.

7

PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule.

Lund-Andersen C, Patzke S, Nähse-Kumpf V, Syljuåsen RG. Lund-Andersen C, et al. Among authors: syljuasen rg. Radiother Oncol. 2014 Feb;110(2):355-61. doi: 10.1016/j.radonc.2013.12.014. Epub 2014 Feb 4. Radiother Oncol. 2014. PMID: 24502970

8

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy.

Halvorsen AR, Helland A, Fleischer T, Haug KM, Grenaker Alnaes GI, Nebdal D, Syljuåsen RG, Touleimat N, Busato F, Tost J, Saetersdal AB, Børresen-Dale AL, Kristensen V, Edvardsen H. Halvorsen AR, et al. Among authors: syljuasen rg. Int J Cancer. 2014 Nov 1;135(9):2085-95. doi: 10.1002/ijc.28862. Epub 2014 Apr 5. Int J Cancer. 2014. PMID: 24658971 Free PMC article.

9

A novel role for ATR/Rad3 in G1 phase.

Bøe CA, Håland TW, Boye E, Syljuåsen RG, Grallert B. Bøe CA, et al. Among authors: syljuasen rg. Sci Rep. 2018 May 2;8(1):6880. doi: 10.1038/s41598-018-25238-6. Sci Rep. 2018. PMID: 29720710 Free PMC article.

10

p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775.

Hauge S, Macurek L, Syljuåsen RG. Hauge S, et al. Among authors: syljuasen rg. Cell Cycle. 2019 Apr;18(8):834-847. doi: 10.1080/15384101.2019.1593649. Epub 2019 Apr 3. Cell Cycle. 2019. PMID: 30943845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page